1. Wang B, Iriguchi S, Waseda M, Ueda N, Ueda T, Xu H, Minagawa A, Ishikawa A, Yano H, Ishi T, Ito R, Goto M, Takahashi R, Uemura Y, Hotta A, Kaneko S. Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. Nature Biomedical Engineering. 2021, (5):429-440, 10.1038/s41551-021-00730-z.
2. Kawai1 Y, Kawana-Tachikawa A, Kitayama S, Ueda T, Miki S, Watanabe A, Kaneko S. Generation of highly proliferative rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy. Molecular Therapy, 2021, 29(10):3027-3041, doi.org/10.1016/j.ymthe.2021.05.016
3. Ito T, Kawai Y, Yasui Y, Iriguchi S, Minagawa A, Ishii T, Miyoshi H, Taketo M. M, Kawada K, Obama K, Sakai Y, Kaneko S. The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte derived iPS cells. Communications Biology, 2021, $(1):694, doi: 10.1038/s42003-021-02195-x.
4. Charneau J, Suzuki T, Shimomura M, Fujinami N, Mishima Y, Hiranuka K, Watanabe N, Yamada T, Nakamura N, Nakatsura T. Development of antigen-prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse. Cancer Science. 2022, 113(4): 1113-1124, doi: 10.1111/cas.15291.
5. Ogiwara Y, Nakagawa M, Nakatani F, Uemura Y, Zhang R, Kudo-Saito C. Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma. Cancer Lett, 2022, 537:215690. doi: 10.1016/j.canlet. 2022.215690.
6. Nosaka K, Suzuki S, Yoshikawa T, Shimomura M, Kitami K, Yoshida K, Yoshihara M, Kikkawa F, Nakatsura T, Kajiyama H, Heat shock protein 105 as an immunotherapeutic target for patients with cervical cancer, Anticancer Research. 2021, 41(10):4741-4751. doi: 10.21873/anticanr es.15289.
7. Charneau J,Suzuki T, Shimomura M, Fujinami N, Nakatsura T. Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances, Journal of Hepatocellular Carcinoma, 2021, 8:1035-1054. doi: 10.2147/JHC.S291558.
8. Shen S, Wu Q, Liu J, Wu L, Zhang R, Uemura Y, Yu X, Chen L, Liu T. Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood. Int J Immunopathol Pharmacol. 2021, 35:20587384211056505. doi: 10.1177/20587384211056505.
9. Kudo-Saito C, Ogiwara Y, Imazeki H, Boku N, Uemura Y, Zhang R, Kawano-Nagatsuma A, Kojima M, Ochiai A. CD11b+DIP2A+LAG3+ cells facilitate immune dysfunction in colorectal cancer. Am J Cancer Res, 2021, 11(11):5428-5439. eCollection 2021.
10. 金子新. iPS細胞を用いたがんに対する免疫療法. 別冊・医学のあゆみ. 2021. 62-65.